Proof of Concept Study to Assess the Pharmacokinetics/Pharmacodynamics of Nemolizumab in Adults With Chronic Pruritus of Unknown Origin (CPUO)
Public ClinicalTrials.gov record NCT07074977. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
An Exploratory Proof of Concept Study to Assess the Pharmacokinetics/Pharmacodynamics (PK/PD) of Nemolizumab in Adult Participants With Chronic Pruritus of Unknown Origin (CPUO)
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The primary objective of this study is to assess the PK/PD relationship of nemolizumab in adult participants aged 18 years or above with chronic pruritus of unknown origin (CPUO) during a 16-week treatment period.
Study identification
- NCT ID
- NCT07074977
- Recruitment status
- Active, not recruiting
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 50 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Oct 20, 2025 (Actual)
- Primary completion
- Dec 2026 (Estimated)
- Completion
- Jan 2027 (Estimated)
- Last update posted
- Jul 27, 2026
2025 – 2027
United States locations
- U.S. sites
- 25
- U.S. states
- 18
- U.S. cities
- 25
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Galderma Investigational Site (site# 8893) | Birmingham | Alabama | 35244 | — |
| Galderma Investigational Site (#8768) | Tucson | Arizona | 85718 | — |
| Galderma Investigational Site (site# 8636) | Fountain Valley | California | 92708 | — |
| Galderma Investigational Site (site# 8130) | Los Angeles | California | 90045 | — |
| Galderma Investigational Site (#9975) | Sacramento | California | 95815 | — |
| Galderma Investigational Site (site# 8021) | San Diego | California | 92123 | — |
| Galderma Investigational Site (site# 7075) | San Francisco | California | 94115 | — |
| Galderma Investigational Site (site# 8608) | Santa Monica | California | 90404 | — |
| Galderma Investigational Site (#8295) | Miami | Florida | 33136 | — |
| Galderma Investigational Site (site# 7054) | Tampa | Florida | 33609 | — |
| Galderma Investigational Site (site# 8142) | Indianapolis | Indiana | 46250 | — |
| Galderma Investigational Site (#7129) | Bowling Green | Kentucky | 42104 | — |
| Galderma Investigational (Site# 7048) | Baltimore | Maryland | 21201 | — |
| Galderma Investigational Site (site# 8743) | Ann Arbor | Michigan | 48109 | — |
| Galderma Investigational Site (site# 8521) | Saint Joseph | Missouri | 64506 | — |
| Galderma Investigational Site (site# 8108) | Las Vegas | Nevada | 89145 | — |
| Galderma Investigational Site (site# 7110) | New City | New York | 10956 | — |
| Galderma Investigational Site (#7130) | The Bronx | New York | 10455 | — |
| Galderma Investigational Site (site# 7111) | Fargo | North Dakota | 58103 | — |
| Galderma Investigational Site (#8212) | Portand | Oregon | 97210 | — |
| Galderma Investigational Site (#8255) | Philadelphia | Pennsylvania | 19103 | — |
| Galderma Investigational (Site # 7131) | Spartanburg | South Carolina | 29307 | — |
| Galderma Investigational Site (site# 8003) | Webster | Texas | 77598 | — |
| Galderma Investigational Site (site# 8862) | Fairfax | Virginia | 22031 | — |
| Galderma Investigational Site (site# 8725) | Morgantown | West Virginia | 26505 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 1 non-U.S. site.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT07074977, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jul 27, 2026 · Synced Oct 18, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT07074977 live on ClinicalTrials.gov.